ArticleBioengineering (Basel, Switzerland)2026
Surgical Treatment of Peri-Implant Defects with L-PRF-Xenograft Bone Blocks: A Prospective Case Series.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The goal of this paper was to determine the efficacy of the surgical treatment of two-wall peri-implant defects filled with L-PRF/xenograft block in the reduction of peri-implant marginal bone levels after 12 months. Ten patients with two-wall peri-implant defects were included. Patients received presurgical treatment followed by a surgical reconstructive intervention with bone blocks obtained by mixing bovine origin xenogeneic bone graft grains with L-PRF membranes. Patients were followed up at 3, 6, 9, and 12 months for oral hygiene and disease relapse evaluation and assessment of the primary outcome marginal bone levels (MBL) and clinical outcome variables such as probing depth (PD), bleeding on probing (BOP), and mucosal recession. Data was analyzed for changes between baseline and the 6- and 12-month follow-ups. Mean MBL was 5.1 ± 1.7 mm and 1.58 ± 0.92 mm at baseline and 6 months after the procedure, indicating a statistically significant decrease (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.